Download:
docx |
pdf
UNITED STATES FOOD & DRUG
ADMINISTRATION
Shortages
Data Collection
OMB Control No. 0910-0491
Request for
non-substantive, non-material change to an approved information
collection:
Added by
section 3112 of the Coronavirus Aid, Relief, and Economic Stability
Act (CARES), FDA is requesting to include information submitted under
section 506J of the Federal Food, Drug, and Cosmetic Act (FD&C
Act) with the information collection. Section 506J of the FD&C
Act (21 USC 356j) requires manufacturers to notify FDA, during or in
advance of a public health emergency, of a permanent discontinuance
in the manufacture of certain devices or an interruption in the
manufacture of certain devices that is likely to lead to a meaningful
disruption in supply of that device in the United States. To
implement this provision we have updated our electronic medical
device registration system to include data elements required under
section 506J and have created a user guide to assist respondents with
submission of notifications. As communicated on our website,
respondents not certain whether to notify FDA about a particular
device or interruption may contact FDA by e-mail at
CDRHManufacturerShortage@fda.hhs.gov
for devices regulated by CDRH, or cbershortage@fda.hhs.gov
for devices regulated by CBER.
Attachments:
How to Use
the Section 506J Template
(August 2021)
21 USC 356j
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Modified | 0000-00-00 |
File Created | 2023-08-21 |